Centene Corporation
Centene Reports 2025 Results and Provides 2026 Guidance
Summary
Centene Corporation announced its financial results for the fourth quarter and full year of 2025, reporting a GAAP diluted loss per share of $(13.53) for the year and an adjusted diluted EPS of $2.08. The company also provided guidance for 2026, expecting adjusted diluted EPS to be greater than $3.00. Key highlights include premium and service revenue growth, a Health Benefits Ratio (HBR) of 94.3% for Q4 2025, and an adjusted SG&A expense ratio of 7.4% for the full year 2025. The 2025 results were impacted by goodwill impairment and non-cash impairment charges, while 2026 guidance reflects improved expectations.
Get alerts for CNC
Be first to know when Centene Corporation files with the SEC.
Filing Categories
Advertisement
About Centene Corporation
Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.
Official SEC Documents
Advertisement